Benamar, K., 7
Bianchi, M., 39
Bodnar, R. J., 499

Carriere, J., 11
Cavallaro, K., 19
Ceccarelli, I., 19
Connolly, G., 3

Ferrario, P., 39

Geller, E. B., 7
Gould, III, H. J., 513
Gould, T. N., 513

Koski, D. M., 11
Krcmery, S., 43
Kulkarni, S. K., 27

Martinez, R. P., 1
Masar, O., 43
Miletic, V., 507
Minor, L., 513

Panerai, A. E., 39
Patil, C. S., 27
Paul, D., 513

Scarmuzzino, A., 19
Schulingkamp, R. J., 47
Shane, R., 499
Shih, A., 507
Singh, A., 27
Smith, L. J., 507
Stamschror, S., 11

Wiertelak, E. P., 11
Wolkin, J., 499

Xin, L., 7

Behavior, 19

Carrageenan, 513
Caudal blockade, 43
Central nervous system, 39
cGMP, 27
Chronic constriction injury model, 507
Companion animals, 3

Delta receptor, 499
Delta-opioid antinociception, 1

Gabapentin, 513

Hyperalgesia, 11, 507, 513

Inflammation, 513

Kappa receptor, 499

Lidocaine, 507
Lipopolysaccharide, 11
Lithium, 1
Lithium chloride, 11

M1 metabolite, 39
Morphine, 7
Mu receptor, 499
 

ORL-1/KOR-3 receptor, 499
Orphanin FQ/nociceptin, 499

Pain, 19, 513
Pain assessment, 3
Periaqueductal gray, 7
Phosphatidylinositol, 1
Plantar test, 19

Rat, 19
Rat plasma, 39

Thalidomide, 11
Tramadol, 39

Basinski, A., 31
Berger, E., 9
Bhalla, A. P., 35
Bobyntsev, I. I., 223
Bozyk, W., 31
Brandt, M. R., 239

Capurso, U., 13
Coeli, S. M. C. M., 49

Del Ángel, R., 67
Dobrogowski, J., 217
Dureja, G. P., 35

Elzo J, J., 63
Enggaard, T. P., 53

Felip, M., 61
Fuchs, P. N., 1

Gimeno, E. B., 61
Golec, A., 217
Gram, L. F., 53
Gumulka, S. W., 75

Isanta, M. R., 61

Jain, N. K., 211
Jayalakshmi, T. S., 35

Kolaric, S., 75
Konrad, H., 49
Kulkarni, S. K., 211

Labuz, D., 217
López, E. T., 67
Liu, X. J., 19
Long, K., 229
Lyashev, Y. D., 223

Makulska-Nowak, H. E., 75
Marini, I., 13
Matsutani, K., 39
McCary, J. D., 83
McCleane, G. J., 45
Meyer, R. A., 1

Negus, S. S., 239

Rabah, E., 63
Raffa, R. B., 83
Raja, S. N., 1

Sawynok, J., 19
Schulingkamp, R. J., 83
Severyanova, L. A., 223
Sindrup, S. H., 53
Singh, A., 211
Smigielska, E., 31
Sotelo, J. C., 61
Souyet, H., 63
Suchorzewski, M., 31

Tsuruoka, M., 39

Vecchiet, F., 13

Xing, J., 229

Xu, H., 229

Yang, H., 229

cAMP-dependent protein kinase, 229
Capsaicin, 1
Celiac plexus block, 31
Chronic postoperative pain, 9
Coeruleotrigeminal antinociception, 39
Complex regional pain syndrome, 49
Complications, 31
Cyclooxygenase-1 enzyme, 211
Cyclooxygenase-2 enzyme, 211

Dorsal root ganglion, 229
Dysesthetic neuropathic pain, 61

Electric stimulation, 67
Epibatidine, 239
Experimental pain, 53

Fosphenytoin, 45

b-Funaltrexamine, 75
Ganglion impar, 63
Ganglion of Walther, 63
Glossopharyngeal neuralgia, 35

Imipramine, 53
Inflammation, 67
Lamotrigine, 61

Locus coeruleus, 39
Lumbar spine surgery, 9

Monkey, 239
Morphine, 239
Multimodality treatment regime, 35
Myofacial trigger points, 13

Naltrindole, 75
Neurolytic block, 63
Neuropathic pain, 1, 19, 45, 49
Neuropeptide effects, 223
Nicotine, 239
Nitric oxide synthesis, 223
NMDA receptor antagonists, 217

Pain, 67
Pain-induced aggression, 223
Pain sensitivity, 223
Paracetamol, 217
Paradoxical analgesia, 75
Paradoxical hypertension, 75
Paroxetine, 53
Perineural fibrosis, 9
Phenytoin, 45
Preferential COX-2 inhibitors, 211
Prostaglandin E₂, 239

Schedule-controlled responding, 239
Selective COX-2 inhibitors, 211
Self-injury behavior, 67
Spontaneous activity, 229
Sympathetic block, 63
Sympathetically maintained pain, 49
Sympathetically mediated pain, 63

Temporomandibular disorders, 13
Temporomandibular joint, 39
Temporomandibular joint dysfunction, 13
Thalamus, 67
Therapeutic treatment, 1
Thermal hypersensitivity, 239
Transcutaneous electrical nerve stimulation, 35

Visual analog scale, 61

Whiplash injury, 13
Work reintegration, 9
Writhing test, 217

Carroll, F. I., 27
Caselli, G., 181
Codd, E. E., 173

Del Angel, R., 475

Fendrick, A. M., 483

Gumulka, S. W., 9

Han, S..-M., 461
Hauser, W. A., 483
Heaton, A. H., 483
Hernández-Matheus, D., 405
Hwang, J.-H., 461

Jasinski, D. R., 19
Johnson, R. E., 19
Jones, H. E., 19

Lee, C., 461
Lee, D.-M., 461
Li, Y., 187
López-Avila, A., 475

Makulska-Nowak, H. E., 9
Manning, D. C., 483
Maszczynska, I., 9
McCary, J. D., 197, 409, 505
McCleane, G., 479
Miranda, H. F., 1
Miwa, Y., 467
Molino, L. J., 173
Morgan, G. J., 483

Park, P.-H., 461
Partilla, J. S., 27
Patrick, C. A., 397
Pelissier, T., 1
Pellicer, F., 475
Pinardi, G., 1
Porter, G. A., 483

Shadiack, A. M., 173
Shank, R. P., 173
Shibuya, N., 467
Singh, G., 483
Sotres-Bayón, F., 475

Thomas, J. B., 27
Tortorici, V., 405
Toyoda, H., 467

Vásquez, E., 405
Vanegas, H., 405

Weiner, D. K., 377
Wild, K. D., 33, 173, 197, 409
Woods, J. H., 397

Yagel, S. K., 173

Zimmerman, D. M., 27

Buprenorphine, 467
BW942C, 19

Carrageenan, 475
Central sensitization, 405
Chronic pain, 9, 483
Chung model, 173
Clonidine, 187
Cyclooxygenase enzyme system, 181
Cytokine modulation, 181

Denervation, 475
Descending pain inhibitory pathways, 9
Dipyrone, 405
Drug approaches, 483

Economics, 483
Enkephalin, 19
Epidural, 467

GTP, 27

Hypertension, 9

Inflammation, 475

Kappa opioids, 397
Ketoprofen, 181

Ligand binding, 27

MK-801, 461
Morphine, 9, 19, 187

Naloxonazine, 1
Naloxone, 9
Neostigmine, 461
Nerve ligation injury, 461
Neuropathic pain, 173, 479
Niltrindole, 1
Nociception, 475
Non-drug approaches, 483
Nor-binaltorphimine, 1
NSAIDS, 483

Pain, 483
Pain assessment, 377
Pentapeptide, 19
Periaqueductal gray, 405
Persistent pain, 377
Pharmacokinetic, 467
Postoperative analgesia, 467
Preemptive analgesia, 467

Rat, 475

Sex difference, 397
Somatic pain, 397
Spinal, 187
Spinal neurons, 405
Subjective effects, 19

Tolerance, 187
Topiramate, 173
Tramadol, 1, 483

Visceral pain, 397

Writhing test, 1

Yohimbine, 1